Capstone Investment Advisors, LLC Clovis Oncology, Inc. Put Options Transaction History

Capstone Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 17, 2021	SELL	$4.81 - $10.34 $577,200 - $1.24 Million	-120,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.82 - $7.72 $385,600 - $617,600	80,000 Added 200.0%	120,000 $700,000
Q2 2020 Aug 14, 2020	SELL	$5.69 - $9.69 $533,722 - $908,922	-93,800 Reduced 70.1%	40,000 $270,000
Q1 2020 May 15, 2020	SELL	$3.77 - $11.0 $160,979 - $469,700	-42,700 Reduced 24.19%	133,800 $851,000
Q4 2019 Feb 14, 2020	BUY	$3.0 - $16.43 $529,500 - $2.9 Million	176,500 New	176,500 $1.84 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Capstone Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capstone Investment Advisors, LLC with notifications on news.